COMPARISON OF AIRWAY NERVE BLOCK VERSUS NEBULIZED LIDOCAINE ON HEMODYNAMIC RESPONSES DURING AWAKE FIBEROPTIC INTUBATION

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorMayo Hospital Lahore

About this trial

This prospective randomized controlled trial aims to compare the effectiveness of airway nerve blocks versus nebulized lidocaine in attenuating hemodynamic responses during awake fiberoptic intubation in adult patients with anticipated difficult airways. Eighty patients undergoing elective surgery requiring awake fiberoptic intubation will be randomly assigned to receive either airway nerve blocks (glossopharyngeal and transtracheal blocks with lidocaine) or nebulized lidocaine. The primary outcome will be changes in heart rate and mean arterial pressure during and after intubation. Secondary outcomes include intubation conditions, patient comfort, cough severity, intubation time, and procedure-related complications. The study aims to identify the most effective airway anesthesia technique for maintaining hemodynamic stability and improving patient tolerance during awake fiberoptic intubation.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • Nebulized Lidocaine

    Drug

    Participants will receive 4% lidocaine administered via nebulization for 15 minutes before awake fiberoptic intubation to provide topical airway anesthesia and suppress airway reflexes during the procedure.

  • Nerve Block

    Procedure/Surgery

    Participants will receive airway anesthesia using bilateral glossopharyngeal nerve block and transtracheal block with 2% lidocaine before awake fiberoptic intubation to provide airway anesthesia and suppress airway reflexes during the procedure.

Treatment groups

80 Participants
are divided into 2 treatment groups
Group A: Nebulized LidocaineExperimental treatment 1 intervention
Group B: Nerve BlockExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Mean Arterial Pressure (MAP) Change During Awake Fiberoptic Intubation

Change in mean arterial pressure from baseline measured during intubation and at 1, 3, and 5 minutes after awake fiberoptic intubation.

Time frame
Baseline to 5 minutes after intubation.
2

Heart Rate Change During Awake Fiberoptic Intubation

Change in heart rate from baseline measured during intubation and at 1, 3, and 5 minutes after awake fiberoptic intubation.

Time frame
Baseline to 5 minutes after intubation.

Secondary outcomes

1

Intubation Time

Time from insertion of the fiberoptic bronchoscope until confirmation of successful endotracheal tube placement.

Time frame
During the intubation procedure.
2

Patient Comfort Score

Patient comfort assessed using a standardized 5-point tolerance scale.

Time frame
Immediately after completion of awake fiberoptic intubation.
3

Cough Severity Score

Severity of coughing during awake fiberoptic intubation assessed using a predefined cough scoring system.

Time frame
During the intubation procedure.
4

Successful Intubation Rate

Successful placement of an endotracheal tube without the need for rescue airway anesthesia.

Time frame
From intervention administration until 5 minutes after intubation.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: